Robert Califf Cytokinetics Inc (CYTK) insider trading activity

CYTK Quotes by TradingView

Robert Califf is Director of CYTOKINETICS INC. Currently has a direct ownership of 6,003 shares of CYTK, which is worth approximately $283,041. The most recent transaction as insider was on Jan 03, 2022, when has been sold 122 shares (Common Stock) at a price of $46.0 per share, resulting in proceeds of $5,612. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K
0% 3M change
0% 12M change
Total Value Held $283,041

Robert Califf Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2022
BUY
Grant, award, or other acquisition
$5,612 $46.0 p/Share
122 Added 1.99%
6,003 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
$5,621 $36.74 p/Share
153 Added 2.54%
5,881 Common Stock
Jul 07 2021
BUY
Grant, award, or other acquisition
$613 $19.77 p/Share
31 Added 0.54%
5,728 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
$4,993 $20.98 p/Share
238 Added 4.01%
5,697 Common Stock
May 12 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 47.81%
5,459 Common Stock
Apr 01 2021
BUY
Grant, award, or other acquisition
$4,986 $24.44 p/Share
204 Added 30.77%
459 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
$4,988 $19.56 p/Share
255 Added 50.0%
255 Common Stock
RC

Robert Califf

Director
South San Francisco, CA

Track Institutional and Insider Activities on CYTK

Follow CYTOKINETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

News

Receive news related to CYTOKINETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYTK